Proteomics case studies

Whether it’s CMC of a complex biological agent, PK for a protein therapeutic that is undergoing modification in vivo, or a purely academic attempt to understand the conformational dynamics associated with activity of an intriguing protein, we will help you leverage the power of ProQuant® to answer the question that matters most to you.

Read our case studies to find out more:

About Us

The ProQuant® platform is offered by RxCelerate following acquisition of Methuselah Health in 2022.

At RxCelerate, we take the time to understand your proteomics question first and then design an approach that has the best chance of giving you the correct answer.

Explore how our drug development expertise, the ProQuant® platform and specialist bioinformatics can support your project.

Got an Enquiry?

Keep up to date

Find out the latest news and updates by following us on LinkedIn: